Among them, STAT1 is involved in anti-tumor immune response, while STAT3 and STAT5 exhibit pro-tumorigenic properties, and their overexpression is closely associated with tumor progression and malignancy (66, 69–71). The gene discussed is STAT1; the disease is neoplasm.